Profound Medical Corp (PRN) — Cash Flow-to-Debt Ratio
Profound Medical Corp (PRN) has a Cash Flow-to-Debt Ratio of -0.60x as of March 2026, meaning its operating cash flow of CA$-11.77 Million could theoretically repay -1% of its total liabilities (CA$19.58 Million) in one year. See PRN working capital ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Profound Medical Corp Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Profound Medical Corp across 12 annual periods. Also explore Profound Medical Corp (PRN) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Profound Medical Corp (2014–2025)
Year-by-year debt coverage analysis for Profound Medical Corp. For market capitalisation and broader financial context, see PRN company net worth.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.52x | CA$-53.39 Million | CA$102.04 Million | ▲ +78.1% |
| 2024 | -2.39x | CA$-23.45 Million | CA$9.81 Million | ▼ -34.6% |
| 2023 | -1.78x | CA$-22.61 Million | CA$12.73 Million | ▲ +14.5% |
| 2022 | -2.08x | CA$-25.80 Million | CA$12.42 Million | ▲ +42.8% |
| 2021 | -3.63x | CA$-22.36 Million | CA$6.16 Million | ▼ -28.0% |
| 2020 | -2.84x | CA$-20.57 Million | CA$7.25 Million | ▼ -188.7% |
| 2019 | -0.98x | CA$-15.33 Million | CA$15.60 Million | ▼ -7.0% |
| 2018 | -0.92x | CA$-13.43 Million | CA$14.63 Million | ▲ +15.1% |
| 2017 | -1.08x | CA$-11.81 Million | CA$10.93 Million | ▲ +34.0% |
| 2016 | -1.64x | CA$-10.79 Million | CA$6.59 Million | ▼ -72.5% |
| 2015 | -0.95x | CA$-4.94 Million | CA$5.21 Million | ▲ +96.6% |
| 2014 | -28.03x | CA$-2.88 Million | CA$102.73K | — |